Lessons Learned from Influenza A(H1N1)pdm09 Pandemic Response in Thailand
Kumnuan Ungchusak , Pathom Sawanpanyalert, Wanna Hanchoworakul, Narumol Sawanpanyalert, Susan A. Maloney, Richard Clive Brown, Maureen Elizabeth Birmingham, and Supamit Chusuttiwat
Author affiliations: Ministry of Public Health, Nonthaburi, Thailand (K. Ungchusak, P. Sawanpanyalert, W. Hanchoworakul, N. Sawanpanyalert, S. Chunsuttiwat); Thailand Ministry of Public Health–US Centers for Disease Control and Prevention, Nonthaburi (S.A. Maloney); World Health Organization, New Delhi, India (R.C. Brown); and; World Health Organization, Nonthaburi (M.E. Birmingham)
Figure 2. . . Third edition (July 17, 2009) of clinical practice guidelines for treatment of patients with suspected influenza A(H1N1)pdm09 virus infection in Thailand. The guidelines were prepared by the Clinical Management Taskforce, Thailand Ministry of Public Health, and experts from medical schools. The guidelines are subject to modification according to the pandemic influenza situation; updates are made available at www.moph.go.th. CXR, chest x-ray; COPD, chronic obstructive pulmonary disease; SLE, systemic lupus erythematosus; DM, diabetes mellitus; bid, twice a day; CAPD, continuous ambulatory peritoneal dialysis; RR, respiratory rate; SpO2, saturation of peripheral oxygen.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.